ERN ReCONNET
COVID-19
European Medicine Agency recommendations
EMA recommendations
The European Medicines Agency is contributing to global efforts to save lives during the COVID-19 pandemic by expediting the development and approval of safe and effective treatments and vaccines, supporting the continued availability of medicines in the European Union, and providing reliable information to patients and healthcare professionals.
The COVID-19 EMA pandemic Task Force is the main tool of EMA and the European medicines regulatory network for enabling EU Member States and the European Commission to take quick and coordinated regulatory action during the pandemic.
In the EMA dedicated webpage you can find the Guidance for medicine developers and companies, informations on potential treatments and vaccines, informations on availability of medicines, and advices for patients and healthcare professionals on the safe use of medicines.
[foogallery id=”8513″]
The COVID-19 EMA pandemic Task Force is the main tool of EMA and the European medicines regulatory network for enabling EU Member States and the European Commission to take quick and coordinated regulatory action during the pandemic.
In the EMA dedicated webpage you can find the Guidance for medicine developers and companies, informations on potential treatments and vaccines, informations on availability of medicines, and advices for patients and healthcare professionals on the safe use of medicines.
